Medicare Enrolled
Dr. Julio Ramos, MD
Rheumatology · Scranton, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ramos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ramos?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ramos
Dr. Julio Ramos is a rheumatology specialist in Scranton, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ramos performed 69,968 Medicare services across 2,357 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ramos received a total of $143,535 from 43 pharmaceutical and/or device companies across 930 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ramos is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 19% volume in PA
$143,535 industry payments
Medicare Practice Summary
Medicare Utilization ↗69,968
Medicare services
Top 19% in PA for rheumatology
2,357
Unique beneficiaries
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,498 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
46,400 | $10 | $50 |
| Denosumab injection (Prolia/Xgeva) | 11,946 | $18 | $40 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
4,740 | $63 | $110 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,772 | $86 | $151 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
992 | $36 | $50 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
865 | $47 | $69 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
642 | $1 | $6 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
542 | $1 | $20 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
541 | $99 | $250 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
297 | $55 | $100 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
230 | $21 | $250 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
161 | $63 | $125 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
142 | $47 | $151 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
104 | $14 | $58 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
88 | $107 | $235 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
88 | $62 | $112 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
76 | $12 | $50 |
| Additional chronic care management time, 60 minutes This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month. |
69 | $55 | $75 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
69 | $3 | $15 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
40 | $131 | $360 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
40 | $101 | $135 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
37 | $94 | $161 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
23 | $11 | $25 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
19 | $123 | $213 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
18 | $59 | $115 |
| Joint fluid aspiration or injection, medium joint Removal of fluid from a medium-sized joint or injection of medication into the joint space. |
14 | $41 | $132 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
13 | $52 | $78 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
67.9% high complexity
26.0% medium
6.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$143,535
Total received (2018-2024)
Avg $20,505/year across 7 years
Top 7% in PA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
930
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$122,259 (85.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,971 (7.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,305 (7.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$34,006
2023
$26,239
2022
$33,181
2021
$4,993
2020
$6,597
2019
$14,986
2018
$23,532
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$32,667
Amgen Inc.
$376
Novartis Pharmaceuticals Corporation
$219
Boehringer Ingelheim Pharmaceuticals, Inc.
$204
Janssen Biotech, Inc.
$170
UCB, Inc.
$115
Organon Llc
$77
GlaxoSmithKline, LLC.
$71
AstraZeneca Pharmaceuticals LP
$37
ANI Pharmaceuticals, Inc.
$29
Radius Health, Inc.
$15
E.R. Squibb & Sons, L.L.C.
$14
Lilly USA, LLC
$13
Top 3 companies account for 97.8% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$90,378
AbbVie, Inc.
$22,631
AbbVie Inc.
$9,236
Janssen Biotech, Inc.
$7,018
GENZYME CORPORATION
$3,964
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,766
Amgen Inc.
$1,492
Novartis Pharmaceuticals Corporation
$1,194
PFIZER INC.
$1,105
UCB, Inc.
$906
Genentech USA, Inc.
$675
Radius Health, Inc.
$459
GlaxoSmithKline, LLC.
$426
E.R. Squibb & Sons, L.L.C.
$310
Lilly USA, LLC
$301
ANI Pharmaceuticals, Inc.
$234
Celgene Corporation
$220
Mallinckrodt Enterprises LLC
$203
Janssen Scientific Affairs, LLC
$192
Mallinckrodt LLC
$186
Organon Llc
$77
AstraZeneca Pharmaceuticals LP
$70
SANOFI-AVENTIS U.S. LLC
$63
Horizon Therapeutics plc
$41
Supernus Pharmaceuticals, Inc.
$36
Takeda Pharmaceuticals U.S.A., Inc.
$31
DePuy Synthes Sales Inc.
$30
MEDAC PHARMA, INC.
$29
Horizon Pharma plc
$27
Alkermes, Inc.
$25
Teva Pharmaceuticals USA, Inc.
$23
Organon LLC
$20
Mallinckrodt Hospital Products Inc.
$19
Allergan Inc.
$18
Indivior Inc.
$17
Sobi, Inc
$17
BioDelivery Sciences International, Inc.
$16
Flexion Therapeutics, Inc.
$16
Greer Laboratories, Inc.
$14
Pacira Therapeutics, Inc.
$14
Kaleo, Inc.
$13
Amarin Pharma Inc.
$12
Purdue Pharma L.P.
$11
Top 3 companies account for 85.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · BENLYSTA · BUNAVAIL 2.1 mg 30-count box · BYSTOLIC · Bimzelx · COSENTYX · Cimzia · EVENITY · Enbrel · Evzio · HADLIMA · HUMIRA · Humira · INFLECTRA · KEVZARA · KRYSTEXXA · Kineret · LYRICA · MONOVISC · NO PRODUCT DISCUSSED · OFEV · ORALAIR · ORENCIA · ORTHOVISC · Otezla · PURIFIED CORTROPHIN GEL · Prolia · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · SUBLOCADE · SYMPROIC · TALTZ · TAVNEOS · TREMFYA · TROKENDI XR · Tavneos · Tymlos · Uloric · VIVITROL · Vascepa · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (85%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for rheumatology in PA.
Geographic Context
Rheumatologists within 10 mi
13
Per 100K population
6.0
County median income
$64,691
Nearest hospital
GEISINGER-COMMUNITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ramos is a mixed practice specialist, with above-average Medicare volume (top 19% in PA), with speaking/promotional industry engagement in the top 7% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ramos experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Ramos performed 46,400 golimumab infusion (simponi aria) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ramos receive payments from pharmaceutical companies?
Yes. Dr. Ramos received a total of $143,535 from 43 companies across 930 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ramos's costs compare to other rheumatologists in Scranton?
Dr. Ramos's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ramos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Scranton
Browse rheumatologists in Scranton ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in PA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in PA
Which PA rheumatologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology